Nextrove is a pioneering company in Life Sciences Professional Services and Solutions, with a mission to "Empower clients to improve Patient Safety." The firm is dedicated to servicing the Pharmaceutical, Biotech, and Contract Research Organizations sectors, offering specialized assistance in areas such as Pharmacovigilance, Hosting, Artificial Intelligence, eTMF, RIM, Regulatory Affairs, Clinical Operations, Medical Information, Salesforce, and Integration services. The company's 'Progressive' suite of solutions has been instrumental in driving efficiency in Pharmacovigilance operations and delivering impressive ROI for clients. Notable components include Progressive Intake, an advanced Adverse Event Collection and Intake application; Progressive Global Follow-up Automation, simplifying and automating follow-up communication with reporters; Progressive Convey, transforming the Investigator/Partner communication process; Progressive Analytics, offering superior scalability and operational efficiencies; and Progressive Compliance, automating safety periodic report generation through AI-driven algorithms. With its headquarters in Princeton, NJ, United States and offices in the UK (Leicester), Italy (Milan), Japan (Tokyo), China (Shanghai), South Korea (Seoul), and India (Noida, Bengaluru, and Mysuru), Nextrove boasts over 20 years of experience in helping clients achieve their global digitalization strategy, maintain regulatory compliance, and significantly reduce the total cost of ownership across various engagements. Having been founded in 2018, the company presents a compelling investment opportunity within the Analytics industry. Although the latest investment details and investors are currently undisclosed, Nextrove's innovative solutions and extensive industry presence position it as a promising prospect for potential investors.
There is no investment information
No recent news or press coverage available for Nextrove.